Article Detail

Home > Article Detail
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

Bioequivalence Evaluation of the Tiropramide Formulation by GC/MS

Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
2001, v.14 no.3, pp.221-229
Myung, Seung-Woon
Kim, Myungsoo
Kim, Hye-Young
Kwak, Hyun-Tae
Min, Hye-Ki
Sohn, Dong-Ryul
Hong, Young-Hun
  • Downloaded
  • Viewed

Abstract

The bioequivalence study of two tiropramide products was evaluated in 16 health male volunteers following intra-muscular injection. Test product was Tiram<TEX>$^{(R)}$</TEX> injection (S Pharm. Co, Ltd.) and reference product was Tiropa<TEX>$^{(R)}$</TEX> injection(D Pharm. Co., Ltd.). The drug concentration in plasma was determined by GC/MS for over a period of 8 hours after injection. Analysis of variance reveal that there are no differences in AUC (area under the plasma concentration-time curve from time zero to infinity), Cmax (maximum plasma concentration) and Tmax (time to reach Cmax). The differences of mean AUC, Cmax and Tmax between two products were 0.73, -1.385 and -12.994%, respectively. Minimum detectable differences (%) at <TEX>${\alpha}

keywords
tiropramide, GC/MS, bioequivalence


상단으로 이동

Analytical Science and Technology